Revenue Breakdown
Composition ()
No data
Revenue Streams
Alpha Teknova Inc (TKNO) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Lab Essentials, accounting for 75.7% of total sales, equivalent to $7.79M. Other significant revenue streams include Clinical Solutions and Other. Understanding this composition is critical for investors evaluating how TKNO navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Alpha Teknova Inc maintains a gross margin of 29.62%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -46.16%, while the net margin is -47.66%. These profitability ratios, combined with a Return on Equity (ROE) of -22.83%, provide a clear picture of how effectively TKNO converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, TKNO competes directly with industry leaders such as CNTB and IPHA. With a market capitalization of $125.40M, it holds a significant position in the sector. When comparing efficiency, TKNO's gross margin of 29.62% stands against CNTB's 100.00% and IPHA's 3.59%. Such benchmarking helps identify whether Alpha Teknova Inc is trading at a premium or discount relative to its financial performance.
